The DINO trial - challenges for translation into clinical practice

Abstract

Infants born prematurely require higher amounts of dietary docosahexaenoic acid (DHA) than can be supplied through current strategies. Increasing the DHA content of breast milk and formula while achievable may not be the most efficacious approach. A new approach is required that enables direct delivery to the infant enabling maximum dose to be achieved as early as possible.